Last reviewed · How we verify

NCT06255769

Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard

Recruiting now Last updated 21 August 2024
What this trial tests

trial testing Magnetocardiography in Chest Pain in 228 participants. Currently enrolling.

Timeline
12 February 2024
Primary endpoint
31 October 2024
31 December 2024

Quick facts

Lead sponsorQilu Hospital of Shandong University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment228
Start date12 February 2024
Primary completion31 October 2024
Estimated completion31 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Qilu Hospital of Shandong University

Who can join

18 and older, any sex, with Chest Pain or Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective clinical study aiming to investigate the efficacy of Magnetocardiography (MCG) in detecting myocardial ischemia in patients of a suspected non-ST-elevation-acute coronary syndrome (NSTE-ACS) by using Single photon emission computed tomography (SPECT) as the gold standard for determining the presence and severity of myocardial ischemia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Magnetocardiography

Trials testing the same drug.

Other recruiting trials for Chest Pain

Currently open trials in the same condition.

Other Qilu Hospital of Shandong University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06255769.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing